tiprankstipranks
Ironwood Pharmaceuticals’ Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsIronwood Pharmaceuticals’ Earnings Call: Growth Amid Challenges
29d ago
Ironwood sees FY25 revenue $260M – $290M, consensus $287.62M
Premium
The Fly
Ironwood sees FY25 revenue $260M – $290M, consensus $287.62M
29d ago
Ironwood reports Q4 EPS 2c, consensus 8c
Premium
The Fly
Ironwood reports Q4 EPS 2c, consensus 8c
29d ago
Ironwood price target lowered to $7 from $8 at Craig-Hallum
PremiumThe FlyIronwood price target lowered to $7 from $8 at Craig-Hallum
2M ago
Ironwood price target lowered to $14 from $23 at JMP Securities
Premium
The Fly
Ironwood price target lowered to $14 from $23 at JMP Securities
2M ago
Ironwood Pharma Announces Major Workforce Cuts and CFO Change
Premium
Company Announcements
Ironwood Pharma Announces Major Workforce Cuts and CFO Change
2M ago
Ironwood jumps after FDA rejects Zealand short bowel syndrome drug application
PremiumThe FlyIronwood jumps after FDA rejects Zealand short bowel syndrome drug application
3M ago
Beam Therapeutics appoints Sravan Emany as CFO
Premium
The Fly
Beam Therapeutics appoints Sravan Emany as CFO
4M ago
Ironwood Pharmaceuticals Reports Q3 2024 Performance
Premium
Company Announcements
Ironwood Pharmaceuticals Reports Q3 2024 Performance
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100